{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:11:15Z","timestamp":1760782275271,"version":"3.44.0"},"reference-count":91,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/028418600750013087","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:24:36Z","timestamp":1027686276000},"page":"319-326","source":"Crossref","is-referenced-by-count":13,"title":["Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis?"],"prefix":"10.2340","volume":"39","author":[{"given":"Thomas","family":"Lindahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Klaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Bj\u00f6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Lindman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"von Schoultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"407","volume":"14","author":"Graversen H","year":"1988","journal-title":"Eur J Surg Oncol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.1992.230","volume":"66","author":"Ivens D","year":"1992","journal-title":"Br J Cancer"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/1097-0142(19810301)47:5<877::AID-CNCR2820470511>3.0.CO;2-3","volume":"47","author":"Swedborg I","year":"1981","journal-title":"Cancer"},{"key":"CIT0004","first-page":"23","volume":"13","author":"Swedborg I","year":"1981","journal-title":"Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehabil Med"},{"key":"CIT0005","first-page":"315","volume":"36","author":"Maunsell E","year":"1993","journal-title":"Arm problems and psychological distress after surgery for breast cancer. Can J Surg"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930500114"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0360-3016(92)90908-Z","volume":"23","author":"Marks L","year":"1992","journal-title":"Cancer and Leukemia Group B. Int .1- Radiat Oncol Biol Phys"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1008252014312","volume":"9","author":"Bergh J","year":"1998","journal-title":"Ann Oncol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"Fisher B","year":"1997","journal-title":"J Clin Oncol"},{"key":"CIT0010","first-page":"347","volume":"2","author":"Mauriac L","year":"1991","journal-title":"Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Re-sults of a randomized trial in a single centre. Ann Oncol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0959-8049(94)90537-1","volume":"30","author":"Scholl S","year":"1994","journal-title":"Eur J Cancer"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.1995.13.3.547","volume":"13","author":"Powles T","year":"1995","journal-title":"J Clin Oncol"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-3-642-45769-2_46","volume":"152","author":"Goldhirsch A","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1098-2388(199609\/10)12:5<321::AID-SSU6>3.0.CO;2-F","volume":"12","author":"Morrow M","year":"1996","journal-title":"Semin Surg Oncol"},{"key":"CIT0015","first-page":"603","volume":"33","author":"Ahlgren J","year":"1994","journal-title":"Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group. Acta Oncol"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/86.23.1771","volume":"86","author":"Ravdin PM","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"CIT0017","first-page":"487","author":"Harris J","year":"1996","journal-title":"Treatment of early-stage breast cancer"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"Veronesi U","year":"1997","journal-title":"Lancet"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199409000-00015"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.3.200"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0092-8674(91)90404-M","volume":"65","author":"Leone A","year":"1991","journal-title":"Cell"},{"key":"CIT0022","first-page":"2325","volume":"8","author":"Leone A","year":"1993","journal-title":"Oncogene"},{"key":"CIT0023","first-page":"8784","volume":"266","author":"Gilles AM","year":"1991","journal-title":"Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem"},{"key":"CIT0024","first-page":"5185","volume":"49","author":"Bevilacqua G","year":"1989","journal-title":"Can-cer Res"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711720107"},{"key":"CIT0026","first-page":"151","volume":"11","author":"Nakamori S","year":"1993","journal-title":"Expression of nucleoside diphosphate kinase\/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI115299","volume":"88","author":"Hailat N","year":"1991","journal-title":"J Clin Invest"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.10.712"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jnci\/88.20.1442","volume":"88","author":"Harris C","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"CIT0030","first-page":"395","volume":"6","author":"Lesoon-Wood LA","year":"1995","journal-title":"Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther"},{"key":"CIT0031","first-page":"1","volume":"55","author":"Clayman GL","year":"1995","journal-title":"In vivo molecu-lar therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<376::AID-IJC12>3.0.CO;2-3","volume":"79","author":"Norberg T","year":"1998","journal-title":"Int J Cancer"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.3-4.173"},{"key":"CIT0034","first-page":"1029","volume":"1","author":"Bergh J","year":"1995","journal-title":"Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Med"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm0996-985","volume":"2","author":"Roth J","year":"1996","journal-title":"Nature Med"},{"issue":"8","key":"CIT0036","first-page":"33","volume":"25","author":"Roth JA","year":"1998","journal-title":"Semin Oncol"},{"key":"CIT0038","first-page":"811","volume":"2","author":"Aas T","year":"1996","journal-title":"Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1998.16.2.470","volume":"16","author":"Clahsen P","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0041","first-page":"787","volume":"71","author":"Linn S","year":"1997","journal-title":"Expression of drug resistance proteins in breast cancer, in relation to chemother-apy. Int J Cancer"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/90.18.1346","volume":"90","author":"Thor A","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"Dameron KM","year":"1994","journal-title":"Science"},{"key":"CIT0046","first-page":"6161","volume":"55","author":"Mukhopadhyay D","year":"1995","journal-title":"Wild-type p53 and v-Src exert opposing influences on human vascular en-dothelial growth factor gene expression. Cancer Res"},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1998.16.9.3121","volume":"16","author":"Linderholm B","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/0140-6736(92)93150-L","volume":"340","author":"Horak ER","year":"1992","journal-title":"Lancet"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.24.1875"},{"key":"CIT0050","first-page":"371","volume":"55","author":"Toi M","year":"1993","journal-title":"Tumor angiogenesis is an independent prognostic indicator in primary breast car-cinoma. Int .1- Cancer"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90344-3"},{"key":"CIT0052","first-page":"745","volume":"8","author":"Siitonen SM","year":"1995","journal-title":"Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0046-8177(95)90190-6","volume":"26","author":"Costello P","year":"1995","journal-title":"Hum Pathol"},{"key":"CIT0054","first-page":"1141","volume":"8","author":"Van Hoef ME","year":"1993","journal-title":"Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.13.997"},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/1040-8428(96)00213-2","volume":"24","author":"Lindblom A","year":"1996","journal-title":"Crit Rev Oncol Hematol"},{"key":"CIT0057","first-page":"1696","volume":"53","author":"Oka H","year":"1993","journal-title":"Cancer Res"},{"key":"CIT0058","first-page":"171","volume":"6","author":"Berx G","year":"1998","journal-title":"Dysregulation of the E-cad-herin\/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun"},{"key":"CIT0059","first-page":"417","volume":"53","author":"Powell WC","year":"1993","journal-title":"Cancer Res"},{"key":"CIT0060","first-page":"4942","volume":"52","author":"Sreenath T","year":"1992","journal-title":"Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res"},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0046-8177(98)90204-0","volume":"29","author":"Tetu B","year":"1998","journal-title":"Hum Pathol"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1073\/pnas.90.5.1843","volume":"90","author":"Wolf C","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"CIT0063","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ijc.2910580614","volume":"58","author":"Engel G","year":"1994","journal-title":"Int J Cancer"},{"key":"CIT0064","first-page":"613","volume":"2","author":"Duffy MJ","year":"1996","journal-title":"Clin Cancer Res"},{"journal-title":"Prognostic and predictive factors. Philadelphia","year":"1996","author":"Clark G","key":"CIT0065"},{"key":"CIT0066","first-page":"6008","volume":"49","author":"Thorpe SM","year":"1989","journal-title":"Cancer Res"},{"key":"CIT0067","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1006115218786","volume":"52","author":"Stephens RW","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1200\/JCO.1994.12.8.1648","volume":"12","author":"Foekens JA","year":"1994","journal-title":"J Clin Oncol"},{"key":"CIT0069","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/bjc.1994.74","volume":"69","author":"Bouchet C","year":"1994","journal-title":"Br J Cancer"},{"key":"CIT0070","first-page":"233","volume":"3","author":"Grondahl-Hansen J","year":"1997","journal-title":"Plasmi-nogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. Clin Cancer Res"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2007-1003527","volume":"13","author":"Hekman CM","year":"1987","journal-title":"Semin Thromb Hemostas"},{"key":"CIT0072","first-page":"9904","volume":"265","author":"Ellis V","year":"1990","journal-title":"Inhibition of receptor-bound urokinase by plasminogen-activator in-hibitors. J Biol Chem"},{"key":"CIT0073","first-page":"1","volume":"68","author":"Andreasen PA","year":"1990","journal-title":"Stacey SN. Plasminogen activator inhibitors: hormonally regulated ser-pins. Mol Cell Endocrinol"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500209"},{"key":"CIT0075","first-page":"4067","volume":"51","author":"Pyke C","year":"1991","journal-title":"The plasminogen activation system in human colon cancer: mes-senger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res"},{"key":"CIT0076","first-page":"435","volume":"62","author":"Montesano R","year":"1990","journal-title":"Increased proteolytic activity is responsi-ble for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell"},{"key":"CIT0077","first-page":"1644","volume":"232","author":"Akiyama T","year":"1986","journal-title":"The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science"},{"key":"CIT0078","first-page":"791","volume":"34","author":"Revillion F","year":"1998","journal-title":"ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer"},{"key":"CIT0079","first-page":"408","volume":"98","author":"Barbareschi M","year":"1992","journal-title":"p53 and c-erbB-2 protein expression in breast carcinoma. Am J Clin Pathol"},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0959-8049(05)80129-7","volume":"28","author":"Berns E","year":"1992","journal-title":"Eur J Cancer"},{"key":"CIT0081","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.1996.14.10.2702","volume":"14","author":"Carlomagno C","year":"1996","journal-title":"J Clin Oncol"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.1992.10.7.1049","volume":"10","author":"Gusterson B","year":"1992","journal-title":"J Clin Oncol"},{"key":"CIT0083","first-page":"2956","volume":"74","author":"Hartmann L","year":"1994","journal-title":"Results from a randomized adjuvant treatment proto-col. Cancer"},{"key":"CIT0084","first-page":"1147","volume":"13","author":"Ji H","year":"1993","journal-title":"c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer. Anticancer Res"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01612634","volume":"116","author":"Marx D","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"CIT0086","first-page":"462","volume":"16","author":"Sj\u00f6gren S","year":"1998","journal-title":"The prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol"},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000227491","volume":"52","author":"Takahashi S","year":"1995","journal-title":"Oncology"},{"key":"CIT0088","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcb.240440307","volume":"44","author":"Tang R","year":"1990","journal-title":"J Cell Biochem"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.2910430205","volume":"43","author":"Guerin M","year":"1989","journal-title":"Int .1- Cancer"},{"key":"CIT0090","first-page":"137","volume":"6","author":"Borg \u00c1, Baldetorp B, Ferno M, Killander D, Olsson H, Sigurdsson","year":"1991","journal-title":"ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene"},{"key":"CIT0091","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"Slamon D","year":"1987","journal-title":"Science"},{"key":"CIT0092","first-page":"2359","volume":"73","author":"Tetu B","year":"1994","journal-title":"The influence of the pattern of immunostaining and adjuvant therapy. Cancer"},{"key":"CIT0093","first-page":"1120","volume":"7","author":"Tandon AK","year":"1989","journal-title":"HER-2\/neu oncogene protein and prognosis in breast cancer. J Clin Oncol"},{"key":"CIT0094","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","volume":"24","author":"Benz C","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1361"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/028418600750013087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:02:56Z","timestamp":1756404176000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/27784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":91,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/028418600750013087"],"URL":"https:\/\/doi.org\/10.1080\/028418600750013087","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"type":"print","value":"0284-186X"},{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}